Skip to main content
. Author manuscript; available in PMC: 2017 Oct 2.
Published in final edited form as: J Perinat Med. 2016 Jan;44(1):77–98. doi: 10.1515/jpm-2015-0103

Table 3.

Concentrations of maternal plasma cytokines and chemokines in the subgroups of clinical chorioamnionitis and term in labor

Analytes
(pg/mL)
Term in labor
(controls)
(n=77)
Clinical chorioamnnionitis at term (n=41)
without intra-amniotic inflammation
(n=8)
with intra-amniotic inflammation without demonstrable
bacteria
(n=9)
with microbial-associated intra-amniotic inflammation
(n=24)
Median
(IQR)
Median
(IQR)
Fold change
(compared
to term in
labor)
Adjuste
d
P-
value*(c
ompare
d to
term in
labor)
Median (IQR) Fold
change
(compar
ed to
term in
labor)
Adjusted
P-value
(compared
to term in
labor)
Adjusted P-
value
(compared to
without intra-
amniotic
inflammation)
Median
(IQR)
Fold
change
(comp
ared to
term in
labor)
Adjusted P-
value
(compared
to term in
labor)
Adjusted
P-value
(compare
d to
without
intra-
amniotic
inflamma
tion)
Adjusted P-
value
(compared
to with
intra-
amniotic
inflammatio
n without
demonstrabl
e bacteria)
Pro-inflammatory cytokines
IL-6 2.53 (1.64–4.08) 6.72 (5.05–12.91) 2.66 0.008 9.75 (6.14–22.92) 3.85 0.009 0.78 15.58 (5.54–22.34) 6.16 <0.0001 0.70 0.92
IL-2 0.01 (0.01–0.12) 0.18 (0.14–0.24) 18.69 0.008 0.12 (0.05–0.14) 12.12 0.27 0.74 0.13 (0.02–0.21) 13.13 0.04 0.40 0.92
IFN-γ 5.24 (3.26–8.34) 88.73 (13.78–135.99) 16.93 0.008 6.15 (3.83–20.57) 1.17 0.45 0.74 5.04 (3.31–7.92) 0.96 0.82 0.08 0.87
TNF-α 2.06 (1.62–2.48) 4.46 (3.2–5.79) 2.17 0.04 2.98 (2.2–3.48) 1.45 0.05 0.74 2.42 (1.55–3.3) 1.17 0.26 0.26 0.87
IL-17α 0.55 (0.34–0.71) 1.32 (0.71–3.87) 2.40 0.04 0.83 (0.68–1.32) 1.51 0.05 0.74 0.74 (0.48–1.07) 1.35 0.09 0.40 0.87
IL-15 2.05 (1.71–2.42) 3.73 (2.93–4.51) 1.82 0.008 2.75 (2.25–3.33) 1.34 0.07 0.74 2.58 (2.23–3.18) 1.26 0.002 0.40 0.97
TNF-β 0.07 (0.02–0.11) 0.1 (0.07–0.11) 1.43 0.51 0.13 (0.08–0.15) 1.86 0.27 0.74 0.1 (0.05–0.15) 1.43 0.11 0.84 0.92
IL-12/IL-23p40 76.89 (62.43–98.69) 112.2 (87.39–147.02) 1.46 0.07 96.63 (58.76–128.84) 1.26 0.30 0.74 83.45 (70.45–101.04) 1.09 0.37 0.31 0.87
IL-16 158.99 (129.21–224.54) 118.8 (89.15–155.07) 0.75 0.13 133.63 (128.67–191.54) 0.84 0.53 0.74 187.65 (159.96–229.7) 1.18 0.31 0.26 0.87
IL-1α 2.61 (1.65–4.27) 2.65 (1.81–3.68) 1.02 0.91 2.7 (2.25–5.08) 1.03 0.53 0.74 2.57 (2.07–3.19) 0.98 0.82 1.00 0.87
GM-CSF 0.02 (0.02–0.09) 0.02 (0.02–0.13) 1.00 0.83 0.02 (0.02–0.17) 1.00 0.53 0.88 0.02 (0.02–0.06) 1.00 0.88 0.90 0.87
IL-7 3.51 (2.04–6.51) 7.79 (3.83–9.14) 2.22 0.15 4.58 (3.68–7.64) 1.3 0.27 0.74 2.72 (1.55–5.07) 0.78 0.27 0.26 0.46
IL-1β 0.12 (0.01–0.31) 0.21 (0.1–0.4) 1.79 0.32 0.31 (0.12–0.35) 2.58 0.27 0.74 0.21 (0.11–0.28) 1.71 0.11 1.00 0.87
IL-12p70 0.07 (0.01–0.13) 0.13 (0.04–0.24) 1.93 0.27 0.13 (0.04–0.21) 1.86 0.15 0.96 0.05 (0.01–0.19) 0.64 0.93 0.30 0.87
VEGF 14.36 (10.67–23.71) 13.98 (10.43–17.51) 0.97 0.61 16.8 (12.11–26.54) 1.17 0.98 0.74 12.21 (9.25–15.12) 0.85 0.19 0.84 0.87
Anti-inflammatory cytokines
IL-10 0.41 (0.25–0.86) 1.9 (1.3–5.42) 4.63 0.02 3.19 (0.92–3.8) 7.78 0.05 0.96 1.75 (0.3–5.49) 4.27 0.05 0.70 0.95
IL-5 0.36 (0.21–0.57) 0.28 (0.2–0.47) 0.79 0.83 0.38 (0.27–0.54) 1.06 0.61 0.74 0.59 (0.4–0.91) 1.64 0.01 0.26 0.87
IL-4 0.03 (0.01–0.03) 0.02 (0.01–0.02) 0.67 0.36 0.02 (0.01–0.03) 0.67 0.81 0.74 0.03 (0.01–0.04) 1.00 0.61 0.40 0.87
IL-13 0.65 (0.28–1.01) 0.28 (0.28–0.41) 0.43 0.07 0.28 (0.28–0.78) 0.43 0.45 0.74 0.93 (0.28–1.37) 1.42 0.27 0.19 0.87
Chemokines
CXCL-10 or IP-10 238.32 (172.2–327.48) 503.96 (284.8–998.46) 2.11 0.02 242.6 (179.13–557.89) 1.02 0.46 0.74 209.99 (169.03–296.8) 0.88 0.70 0.08 0.87
Eotaxin-3 19.36 (14.89–25.59) 10.12 (0.64–22.92) 0.52 0.22 4.67 (0.64–9.54) 0.24 0.008 0.74 3.93 (0.64–12.97) 0.20 0.0003 0.84 0.92
MCP-4 43.79 (29.91–73.38) 33.11 (25.28–52.48) 0.76 0.50 38.85 (34.99–46.92) 0.89 0.98 0.74 26.05 (22.15–37.84) 0.59 0.003 0.40 0.41
MCP-1 57.38 (51.48–70.38) 94.93 (65.69–130.46) 1.65 0.07 73.01 (55.47–91.16) 1.27 0.27 0.74 69.27 (52.17–99.48) 1.21 0.26 0.47 0.92
MIP-1β 59.25(45.93–78.56) 68.62 (52.61–165.9) 1.16 0.29 57.28 (44.39–69.42) 0.97 0.81 0.74 60.51 (38.55–80.72) 1.02 0.82 0.40 0.92
MIP-1α 10.41 (7.35–12.25) 20.64 (9.81–25.13) 1.98 0.10 11.84 (8.95–13.77) 1.14 0.41 0.74 12.63 (9.4–15.2) 1.21 0.11 0.40 0.92
IL-8 3 (1.9–5.09) 4 (2.77–7.97) 1.33 0.44 3.58 (3.43–4.71) 1.19 0.27 0.96 3.61 (3.14–8.6) 1.20 0.09 1.00 0.92
TARC 34.99 (18.74–52.3) 26.89 (21.74–34.94) 0.77 0.50 42.57 (20.45–73.51) 1.22 0.53 0.74 36.75 (24.22–55.2) 1.05 0.61 0.40 0.92
MDC 520.65 (443.02–644.53) 526.94 (471.77–590.9) 1.01 0.73 463.75 (421.72–732.89) 0.89 0.98 0.78 512.05 (396.98–639.64) 0.98 0.68 1.00 0.87
Eotaxin 56.8 (43.72–77.74) 47.95 (41.02–58.23) 0.84 0.27 40.04 (31.29–54.04) 0.70 0.10 0.74 46.68 (32.87–57.96) 0.82 0.08 1.00 0.92

CXCL-10: C-X-C motif chemokine 10; GM-CSF: granulocyte macrophage colony-stimulating factor; IFN-γ: interferon-gamma; IL: interleukin; IP-10: interferon-gamma-induced protein 10; IQR: interquartile range; MCP: monocyte chemoattractant protein; MDC: macrophage-derived chemokine; MIP: macrophage inflammatory protein; TARC: thymus and activation-regulated chemokine; TNF: tumor necrosis factor; VEGF: vascular endothelial growth factor. The units of all analytes are pg/mL.